Sotera Health (SHC) – Investment Analysts’ Recent Ratings Changes

Several brokerages have updated their recommendations and price targets on shares of Sotera Health (NASDAQ: SHC) in the last few weeks:

• 8/11/2026 – Sotera Health was upgraded by Weiss Ratings from “hold (c)” to “hold (c+)”.
• 8/7/2026 – Sotera Health had its price target raised by Citigroup Inc. from $23.00 to $25.00. They now have a “buy” rating on the stock.
• 8/7/2026 – Sotera Health had its price target raised by Barclays PLC from $19.00 to $22.00. They now have an “overweight” rating on the stock.
• 8/7/2026 – Sotera Health had its “overweight” rating reaffirmed by Piper Sandler. They now have a $25.00 price target on the stock, up from $22.00.
• 8/7/2026 – Sotera Health had its price target raised by JPMorgan Chase & Co. from $16.00 to $18.00. They now have a “neutral” rating on the stock.
• 7/9/2026 – Sotera Health was upgraded by Weiss Ratings from “hold (c-)” to “hold (c)”.

Insider Buying and Selling

In related news, Chairman Michael B. Jr. Petras sold 850,000 shares of Sotera Health stock in a transaction on Monday, August 17th. The stock was sold at an average price of $18.50, for a total value of $15,725,000.00. Following the transaction, the chairman directly owned 3,969,393 shares in the company, valued at $73,433,770.50. The trade was a 17.64% decrease in their position. The sale was disclosed in a legal filing with the SEC, which is available through this link. Also, insider Michael P. Rutz sold 150,000 shares of the business’s stock in a transaction that occurred on Friday, August 7th. The shares were sold at an average price of $18.84, for a total transaction of $2,826,000.00. Following the sale, the insider owned 334,279 shares in the company, valued at $6,297,816.36. This represents a 30.97% decrease in their position. The disclosure for this sale is available in the SEC filing. Insiders sold 1,294,515 shares of company stock valued at $23,999,528 over the last 90 days. 15.36% of the stock is currently owned by insiders.

Sotera Health Inc (NASDAQ: SHC) is a global provider of sterilization and laboratory testing services that support the medical device, pharmaceutical, life sciences and consumer product industries. Headquartered in Jacksonville, Florida, the company offers a suite of services designed to ensure products meet rigorous safety and regulatory requirements before reaching market.

Sotera Health operates through three primary service platforms. Its Sterigenics division delivers contract sterilization solutions, including ethylene oxide (EtO), gamma irradiation, electron beam and X-ray technologies.